Stock listing

Dusseldorf:JNJ Johnson & Johnson Aktie

German listing (Dusseldorf) of Johnson & Johnson · home listing NYSE:JNJ

Follow Johnson & Johnson into a list and get an email when it puts out news.

Share price · DUS:JNJ

€246.55 EUR +5.55 (+2.3%)

Close on Oct 30, 2026

Day range
€246.55 – €250.25 EUROct 30, 2026
Market cap
€419.1B EURAt the close on Oct 30, 2026 · price × 1.70B shares outstanding
Johnson & Johnson logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NYSE:JNJ · Home$273.20 USD-2.00 (-0.7%)8,948,945$280.00$282.02$273.13$275.20Close on Oct 30, 2026
BCBA:JNJ$30,280 ARS-40 (-0.1%)11,309$30,660$31,080$30,160$30,320Close on Oct 30, 2026
Xetra:JNJ€239.95 EUR+4.90 (+2.1%)1,123€238.40€241.20€237.35€235.05Close on Oct 27, 2026
B3:JNJB3496.00 BRL+6.51 (+7.3%)10,53595.9596.0093.9789.49Close on Oct 27, 2026
BMV:JNJ$5,008.00 MXN+79.71 (+1.6%)464$4,964.40$5,008.00$4,964.40$4,928.29Close on Oct 27, 2026
Cboe Canada:JNJ$34.16 CAD+0.66 (+2.0%)6,825$33.85$34.21$33.85$33.50Close on Oct 27, 2026
Frankfurt:JNJ€244.60 EUR+1.85 (+0.8%)382€248.65€251.45€244.60€242.75Close on Oct 30, 2026
Munich:JNJ€240.95 EUR+4.05 (+1.7%)8€238.70€240.95€238.70€236.90Close on Oct 27, 2026
Hamburg:JNJ€247.05 EUR+6.90 (+2.9%)—€248.60€248.60€247.05€240.15Close on Oct 30, 2026
Dusseldorf:JNJ€246.55 EUR+5.55 (+2.3%)—€248.25€250.25€246.55€241.00Close on Oct 30, 2026
Ticker
Dusseldorf:JNJ
Asset type
Stock
Exchange
Dusseldorf
Currency
EUR

What changed lately

Calls

Replays

  • Johnson & Johnson (NYSE:JNJ) Q3 2026 Earnings Call

    Tue, Oct 13, 2026 · 8:30 AM ET

    Watch Transcript

  • Johnson & Johnson (NYSE:JNJ) Q2 2026 Earnings Call

    Wed, Jul 15, 2026 · 8:30 AM ET

    Watch Transcript

  • Johnson & Johnson (NYSE:JNJ) Q1 2026 Earnings Call

    Tue, Apr 14, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Johnson & Johnson: Record 26 Abstracts at TCT 2026 Adds to More than 20 Years of Data Demonstrating the Safety, Efficacy and Cost Effectiveness of Impella Heart Pumps

Oct 29, 2026

Johnson & Johnson to Host Enterprise Business Review

Oct 27, 2026

Subcutaneous RYBREVANT®▼ (amivantamab) demonstrates 77% overall response rate in first-line treatment of patients with certain types of advanced head and neck cancer

Oct 25, 2026

RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) combination demonstrates 77% overall response rate in first-line treatment of patients with advanced head and neck cancer

Oct 25, 2026

Johnson & Johnson reports 75% tumor response rate in advanced prostate cancer with JNJ-6143, a first-in-class RIPTAC™ molecule

Oct 25, 2026

Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk localised or locally advanced prostate cancer

Oct 24, 2026

Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer

Oct 24, 2026

Johnson & Johnson advances the next generation of solid tumor therapies with new data at ESMO 2026

Oct 23, 2026

European Commission approves Johnson & Johnson’s TECVAYLI®▼ (teclistamab) monotherapy for relapsed/refractory multiple myeloma, expanding treatment options from first relapse

Oct 23, 2026

Quarterly Report for Quarter Ending September 27, 2026 (Form 10-Q)

Oct 21, 2026

All Johnson & Johnson news

Decks

Johnson & Johnson on 6ix

News releases
183 in the last 12 months · 199 in all · newest Oct 29, 2026 · oldest 2025
Calls
31 calls with a replay · 31 with a transcript · latest Oct 13, 2026
Decks
69 decks · latest Oct 13, 2026

Where Johnson & Johnson is listed

ListingExchangeCountryCurrency
NYSE:JNJ · Home listingNYSEUnited StatesUSD
gettex:JNJgettexGermanyEUR
BCBA:JNJBCBAArgentinaARS
Xetra:JNJXetraGermanyEUR
B3:JNJB34B3BrazilBRL
Tradegate:JNJTradegateGermanyEUR
SET:JNJ03SETThailandTHB
BCBA:JNJDBCBAArgentinaUSD
TSX:JNJTSXCanadaCAD
LS Exchange:853260LS ExchangeGermanyEUR
BMV:JNJBMVMexicoMXN
Cboe Canada:JNJCboe CanadaCanadaCAD
BVC:JNJBVCColombiaCOP
Milan:1JNJMilanItalyEUR
Lang & Schwarz:853260Lang & SchwarzGermanyEUR
Frankfurt:JNJFrankfurtGermanyEUR
Munich:JNJMunichGermanyEUR
Turquoise:JNJNTurquoiseUnited KingdomUSD
Stuttgart:JNJStuttgartGermanyEUR
LSE:0R34LSEUnited KingdomUSD
EUROTLX:4JNJEUROTLXItalyEUR
VIE:JNJViennaAustriaEUR
BOATS:JNJBOATSUnited StatesUSD
BCBA:JNJCBCBAArgentinaUSD
BCS:JNJCLBCSChileCLP
SIX Swiss:JNJ.USDSIX SwissSwitzerlandUSD
Hamburg:JNJHamburgGermanyEUR
Hanover:JNJHanoverGermanyEUR
BIVA:JNJBIVAMexicoMXN
BCS:JNJBCSChileUSD
Dusseldorf:JNJ · This pageDusseldorfGermanyEUR
BX Swiss:JNJBX SwissSwitzerlandCHF
BSESOF:JNJBSESOFBulgariaEUR
SIX Swiss:JNJSIX SwissSwitzerlandCHF
BCBA:JNJ.BBCBAArgentinaARS
Aquis:JNJDAquisUnited KingdomEUR
BVL:JNJUSBVLPeruPEN
gettex:JNJ0gettexGermanyEUR
BX Swiss:JNJUSDBX SwissSwitzerlandUSD
Aquis:JNJDAquisUnited KingdomEUR
Dusseldorf:JNJ0DusseldorfGermanyEUR
Frankfurt:JNJ0FrankfurtGermanyEUR
Lang & Schwarz:A3ET7SLang & SchwarzGermanyEUR
LS Exchange:A3ET7SLS ExchangeGermanyEUR
Munich:JNJ0MunichGermanyEUR
BCBA:JNJ.CIBCBAArgentinaARS

Log in to ask 6ix AI your own questions about Johnson & Johnson.